Digital signature standards group lowers fees

SAFE-BioPharma Association, the drug industry group that champions standards for verifying digital identities, has changed its fee structure. "We are systematically bringing down the cost," CEO Mollie Shields-Uehling said during an interview with FierceBiotech IT at DIA. For companies with 2,000 or fewer employees, the fee is now $50 per year per digital signer.

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.